137 related articles for article (PubMed ID: 2419769)
1. Dissociation between circling behaviour and striatal dopamine activity following unilateral deltamethrin administration to rats.
Brodie ME; Opacka J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):341-6. PubMed ID: 2419769
[TBL] [Abstract][Full Text] [Related]
2. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
3. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
Jaffer A; van der Spuy GD; Russell VA; Mintz M; Taljaard JJ
Neurodegeneration; 1995 Jun; 4(2):139-45. PubMed ID: 7583677
[TBL] [Abstract][Full Text] [Related]
4. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
Olds ME
Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
[TBL] [Abstract][Full Text] [Related]
5. [Effects of pyrethroids on dopamine and its metabolites in nigrostriatum of male rats].
Liu GP; Shi N; Liang JH; Chen L
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):368-70. PubMed ID: 15555315
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
8. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Rouillard C; Bédard P; Falardeau P; Di Paolo T
Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
[TBL] [Abstract][Full Text] [Related]
9. Intranigral GABAergic drug effects on striatal dopamine activity.
Sperber EF; Wurpel JN; Sharpless NS; Moshé SL
Pharmacol Biochem Behav; 1989 Apr; 32(4):1067-70. PubMed ID: 2477863
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
11. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus.
Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C
Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine on motor behavior and on striatal neuropeptide Y neurons.
Nitsch C; Wolfrum G; Schaefer F; Scotti AL; Unger J
Brain Res Bull; 1993; 30(1-2):21-32. PubMed ID: 8420631
[TBL] [Abstract][Full Text] [Related]
13. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
[TBL] [Abstract][Full Text] [Related]
14. Circling behavior following unilateral kainic acid injections into rat striatum.
Taylor RJ; Reavill C; Jenner P; Marsden CD
Eur J Pharmacol; 1981 Dec; 76(2-3):211-22. PubMed ID: 7333356
[TBL] [Abstract][Full Text] [Related]
15. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
Kelly E; Jenner P; Marsden CD
Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
[TBL] [Abstract][Full Text] [Related]
17. Contralateral circling induced by tegmental morphine: anatomical localization, pharmacological specificity, and phenomenology.
Holmes LJ; Wise RA
Brain Res; 1985 Feb; 326(1):19-26. PubMed ID: 3971145
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine hydroxylase as a target for deltamethrin in the nigrostriatal dopaminergic pathway.
Liu GP; Ma Q; Shi N
Biomed Environ Sci; 2006 Feb; 19(1):27-34. PubMed ID: 16673815
[TBL] [Abstract][Full Text] [Related]
19. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
[TBL] [Abstract][Full Text] [Related]
20. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
Waldmeier PC; Feldtrauer JJ; Kam R; Stöcklin K
Eur J Pharmacol; 1979 Mar; 54(3):279-87. PubMed ID: 428427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
